A novel anti-CEACAM5 monoclonal antibody, CC4, suppresses colorectal tumor growth and enhances NK cells-mediated tumor immunity.
Carcinoembryonic antigen (CEA, CEACAM5, and CD66e) has been found to be associated with various types of cancers, particularly colorectal carcinoma, and developed to be a molecular target for cancer diagnosis and therapy. In present study, we generated a novel anti-CEACAM5 monoclonal antibody, namel...
Enregistré dans:
Auteurs principaux: | Chaogu Zheng, Jing Feng, Di Lu, Ping Wang, Shu Xing, Jean-Luc Coll, Dongling Yang, Xiyun Yan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2011
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f470a044dc7b4305b9f30b2c55428f36 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.
par: Ariane Desselle, et autres
Publié: (2012) -
Monoclonal antibodies and Fc fragments for treating solid tumors
par: Eisenbeis AM, et autres
Publié: (2012) -
Preparation of mouse monoclonal antibody for RB1CC1 and its clinical application.
par: Yusuke Hama, et autres
Publié: (2012) -
Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
par: Tanaka T, et autres
Publié: (2014) -
The strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicity.
par: Gábor Szalóki, et autres
Publié: (2014)